Zobrazeno 1 - 3
of 3
pro vyhledávání: '"M Nanette Santoro"'
Autor:
N Maritza Dowling, Carey E Gleason, Joann E Manson, Howard N Hodis, Virginia M Miller, Eliot A Brinton, Genevieve Neal-Perry, M Nanette Santoro, Marcelle Cedars, Rogerio Lobo, George R Merriam, Whitney Wharton, Frederick Naftolin, Hugh Taylor, S Mitchell Harman, Sanjay Asthana
Publikováno v:
PLoS ONE, Vol 8, Iss 7, p e68741 (2013)
ObjectivesWhile global measures of cardiovascular (CV) risk are used to guide prevention and treatment decisions, these estimates fail to account for the considerable interindividual variability in pre-clinical risk status. This study investigated he
Externí odkaz:
https://doaj.org/article/f0c380ffeb7f4010a494d02fa0c3f89d
Autor:
S. Mitchell Harman, Matthew J. Budoff, Whitney Wharton, M. Nanette Santoro, Howard N. Hodis, Hugh S. Taylor, Cynthia M. Carlsson, Rogerio A. Lobo, JoAnn E. Manson, Dennis M. Black, Frederick Naftolin, N. Maritza Dowling, Sanjay Asthana, Carey E. Gleason, Virginia M. Miller, Genevieve Neal-Perry, Eliot A. Brinton, George R. Merriam, Marcelle I. Cedars
Publikováno v:
Journal of Alzheimer's disease : JAD, vol 40, iss 2
Midlife vascular risk factors influence later cognitive decline and Alzheimer's disease (AD). The decrease in serum estradiol levels during menopause has been associated with cognitive impairment and increased vascular risk, such as high blood pressu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a04e85fe2f4f3e74ea6f74d6903c2256
https://europepmc.org/articles/PMC4367860/
https://europepmc.org/articles/PMC4367860/
Autor:
Eliot A. Brinton, Whitney Wharton, N. Maritza Dowling, M. Nanette Santoro, JoAnn E. Manson, George R. Merriam, Carey E. Gleason, Frederick Naftolin, Genevieve Neal-Perry, Howard N. Hodis, Rogerio A. Lobo, Sanjay Asthana, Marcelle I. Cedars, S. Mitchell Harman, Virginia M. Miller, Hugh S. Taylor
Publikováno v:
PLoS ONE
PLoS ONE, Vol 8, Iss 7, p e68741 (2013)
PLoS ONE, Vol 8, Iss 7, p e68741 (2013)
ObjectivesWhile global measures of cardiovascular (CV) risk are used to guide prevention and treatment decisions, these estimates fail to account for the considerable interindividual variability in pre-clinical risk status. This study investigated he